Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments.


Updates from The Motley Fool

Latest updates on Bristol-Myers Squibb from Fool.com.  The Fool has written over 900 articles on Bristol-Myers Squibb.
3 Reasons Bristol-Myers Is a Buy

Image source: Bristol-Myers Squibb. Fresh off a data release announcement providing full details ...



Stock Performance

View Interactive BMY Charts
Sponsored by

Key Data Points

Primary metrics and data points about Bristol-Myers Squibb.
Current Price: $54.52
Prev Close: $56.03
Open: $55.55
Bid: $54.48
Ask: $54.49
Day's Range: $54.36 - $55.68
52wk Range: $49.03 - $77.12
Volume: 4,491,368
Avg Vol 11,752,107
Market Cap: $91B
P/E (ttm): 18.19
EPS (ttm): $3.08
Div & Yield: $1.52 (2.7%)

Company Rating

What our community thinks about Bristol-Myers Squibb.
CAPS Rating 4 out of 5
 
1747 Outperform
113 Underperform
CAPS All Stars
 
433 Outperform
15 Underperform

How do you think Bristol-Myers Squibb will perform against the market?



You pick for Bristol-Myers Squibb is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Giovanni Caforio, CEO

86% Approve

Based on 164 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Bristol-Myers Squibb.

Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments.

  • Exchange: NYSE
  • Sector: Healthcare
  • Industry: Drug Makers